Better Buy: Pfizer vs. BioNTech

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) together pulled off one of the greatest accomplishments in medical history by developing a safe and highly effective COVID-19 vaccine in only a matter of months. That vaccine has already been given to millions of people in multiple countries.

To call what Pfizer and BioNTech achieved a success is an understatement. However, the immediate outcomes of that success have been quite different for the two drugmakers' stocks. BioNTech's shares have more than tripled since the beginning of 2020, while Pfizer stock is basically flat.

Which of these partners' stocks is the better buy going forward? Here's how Pfizer and BioNTech stack up against each other.

Continue reading

Source Fool.com